Trophic effects of adipose derived stem cells on Langerhans islets viability — Review
Langerhans islets transplantation has been proposed to provide an endogenous source of insulin in Type I diabetes. However, the hypoxic stress and the receptor's immune reaction suffered by the implants cause them to fail in sustaining the insulin production along the time. Experimental studies have shown that adipose derived stem cells (ADSCs) can secrete cytokines that activate free radical scavengers, antioxidants and chaperone heat/shock proteins leading to reduction of apoptosis in damaged tissues.
Source: Transplantation Reviews - Category: Transplant Surgery Authors: Isa Dietrich, Alessandra Crescenzi, Elezar Chaib, Luiz Augusto Carneiro D’Albuquerque Source Type: research
More News: Diabetes | Endocrinology | Insulin | Nutrition | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants